- Generic name
- Rifampicin
- Strength
- 150 mg
- Dosage form
- Capsule
- Manufactured by
- The ACME Laboratories Ltd.
A Rifam Capsule
About A Rifam 150 mg Capsule
A Rifam is a capsule from The ACME Laboratories Ltd., with the generic name Rifampicin. In tuberculosis it is given together with other medicines rather than alone, because bacteria can quickly become resistant when a single medicine is used.
There are 18 brands of Rifampicin listed in Bangladesh. The lowest listed price is Firifam 150 mg Tablet at ৳ 1 per unit.
What is A Rifam 150 mg Capsule?
A Rifam is a capsule from The ACME Laboratories Ltd., with the generic name Rifampicin. It is usually taken as part of a combination regimen for tuberculosis, and the doctor decides the exact dose and duration. Rifampicin belongs to a group of medicines called anti-tubercular antibiotics. Always follow the prescriber's instructions and never self-medicate.
Uses of A Rifam
In tuberculosis it is given together with other medicines rather than alone, because bacteria can quickly become resistant when a single medicine is used. Doctors may take samples for culture before starting therapy to confirm that the bacteria respond to Rifampicin. Do not use it for other infections without medical advice. Your doctor will decide if it is suitable for you.
How to use A Rifam
Swallow the capsule with a full glass of water. A Rifam is taken by mouth. Do not stop or change the schedule without medical advice. The dose and duration of treatment depend on your individual condition and will be decided by your doctor.
Side effects of A Rifam
Rifampicin commonly causes an orange-red discolouration of urine, faeces, sweat, saliva, sputum, tears, and other body fluids; this is expected and not harmful. Report severe or persistent symptoms to your doctor promptly. Serious effects include liver problems, blood disorders, kidney problems, and severe skin reactions. Tell your doctor about any side effect that worries you. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
Do not take A Rifam 150 mg capsule if you have a history of allergy to Rifampicin or other rifamycins. Rifampicin can cause liver dysfunction; patients with liver impairment should use it only if necessary and under strict medical supervision, with liver function monitoring. Your doctor may monitor your liver function during treatment. Tell your doctor about all the other medicines you take.
Frequently asked questions
Why is A Rifam prescribed?
In tuberculosis it is given together with other medicines rather than alone, because bacteria can quickly become resistant when a single medicine is used. Doctors may take samples for culture before starting therapy to confirm that the bacteria respond to Rifampicin.
How should I take A Rifam?
Swallow the capsule with a full glass of water. A Rifam is taken by mouth.
Can A Rifam cause side effects?
Rifampicin commonly causes an orange-red discolouration of urine, faeces, sweat, saliva, sputum, tears, and other body fluids; this is expected and not harmful. Report severe or persistent symptoms to your doctor promptly.
Who should be careful with A Rifam?
Do not take A Rifam 150 mg capsule if you have a history of allergy to Rifampicin or other rifamycins. Rifampicin can cause liver dysfunction; patients with liver impairment should use it only if necessary and under strict medical supervision, with liver function monitoring.
Also available as
Indications
Pharmacology
Dosage & Administration
Tuberculosis:
- Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV
- Pediatric Patients: 10–20 mg/kg, not to exceed 600 mg/day, oral or IV
Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of shortcourse therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.
Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.
Interaction
Contraindications
Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance.
Side Effects
Pregnancy & Lactation
Nursing Mothers: Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Precautions & Warnings
In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment. An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition.
Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase. Isolated reports have associated porphyria exacerbation with rifampin administration.
Overdose Effects
Liver enlargement, possibly with tenderness, can develop within a few hours after severe overdosage; bilirubin levels may increase and jaundice may develop rapidly. Hepatic involvement may be more marked in patients with prior impairment of hepatic function. Other physical findings remain essentially normal. A direct effect upon the hematopoietic system, electrolyte levels, or acid-base balance is unlikely.
Facial or periorbital edema has also been reported in pediatric patients. Hypotension, sinus tachycardia, ventricular arrhythmias, seizures and cardiac arrest were reported in some fatal cases.
Storage Conditions
Alternative brands of Rifampicin
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.